AIM
DGX icon

Advantage Investment Management’s Quest Diagnostics DGX Stock Holding History

Advantage Investment Management’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		$27K Sell
256
-10
-4% -$1.03K 0.02% 459
2019
Q2 		$27K Buy
266
+79
+42% +$7.59K 0.02% 462
2019
Q1 		$17K Buy
+187
New +$16.2K 0.01% 550
2017
Q4 		– Sell
-45
Closed -$4K – 1018
2017
Q3 		$4K Sell
45
-29
-39% -$3.08K ﹤0.01% 847
2017
Q2 		$8K Buy
+74
New +$7.82K ﹤0.01% 744

Other funds holding DGX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
FMI
Fiduciary Management Inc Milwaukee, Wisconsin $8.06B AUM 6.78% 1-Year Est. Return
DSA
Davis Selected Advisers Tucson, Arizona $21.8B AUM 23.45% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
MWNA
Marshall Wace North America New York $23.5B AUM 46.46% 1-Year Est. Return

Advantage Investment Management's DGX Position: Q3 2019 in Review

Advantage Investment Management reduced its Quest Diagnostics (DGX) stake by 3.8% in Q3 2019, selling an estimated $1.03K and leaving 256 shares worth $27K. The position accounts for 0.02% of the portfolio, ranked #459.

Advantage Investment Management first reported a position in DGX in Q2 2017 and has held it in 5 quarters since. 676 funds tracked by Wall St. Rank hold DGX as of Q3 2019.

  • Advantage Investment Management held 256 shares of Quest Diagnostics worth $27K as of Q3 2019.
  • Advantage Investment Management sold 10 Quest Diagnostics shares in Q3 2019, an estimated $1.03K.
  • Quest Diagnostics made up 0.02% of Advantage Investment Management's portfolio in Q3 2019, its #459 holding.
  • Advantage Investment Management first reported a position in Quest Diagnostics in Q2 2017 and has held it in 5 quarters since.
  • 676 funds tracked by Wall St. Rank held Quest Diagnostics as of Q3 2019.

Based on Advantage Investment Management's 13F filing for Q3 2019, filed 8 Oct 2019.